Spire Healthcare Group PLC
ISIN: GB00BNLPYF73 | Ticker: SPI | LEI: 213800IBJPW3SE2RA350
Country: United Kingdom
Spire Healthcare Group PLC is a leading provider of private healthcare services in the United Kingdom. The company operates 39 private hospitals and clinics across the UK, offering a wide range of medical services, including diagnostics, oncology, orthopedics, cardiology, and women's health.
Spire Healthcare Group PLC is committed to providing high-quality patient care and is staffed by a team of experienced medical professionals who are dedicated to delivering the best possible outcomes for their patients. The company's hospitals are equipped with state-of-the-art medical technology and facilities, and its medical teams are constantly updating their skills and knowledge to provide the latest and most effective treatments.
2007
Served areaUnited Kingdom
Headquarters3 Dorset Rise, EC4Y 8EN London – United Kingdom
| Line item in (gbp) | 01.01.2020 | 01.01.2021 | 01.01.2022 |
|---|---|---|---|
| Assets | N/A | 2,104,800,000.00 | 2,237,400,000.00 |
| Noncurrent Assets | N/A | 1,854,700,000.00 | 1,890,600,000.00 |
| Property Plant And Equipment | N/A | 1,535,300,000.00 | 1,553,500,000.00 |
| Current Assets | N/A | 250,100,000.00 | 346,800,000.00 |
| Inventories | N/A | 37,600,000.00 | 40,200,000.00 |
| Trade And Other Current Receivables | N/A | 101,400,000.00 | 99,200,000.00 |
| Cash and cash equivalents | 90,800,000.00 | 106,300,000.00 | 202,600,000.00 |
| Current Assets Other Than Assets Or Disposal Groups Classified As Held For Sale Or As Held For Distribution To Owners | N/A | 245,300,000.00 | 342,000,000.00 |
| Noncurrent Assets Or Disposal Groups Classified As Held For Sale Or As Held For Distribution To Owners | N/A | 4,800,000.00 | 4,800,000.00 |
| Equity And Liabilities | N/A | 2,104,800,000.00 | 2,237,400,000.00 |
| Equity | 939,900,000.00 | 706,600,000.00 | 704,800,000.00 |
| Issued Capital | N/A | 4,000,000.00 | 4,000,000.00 |
| Retained Earnings | N/A | -496,400,000.00 | -496,100,000.00 |
| Share Premium | N/A | 826,900,000.00 | 826,900,000.00 |
| Capital Reserve | N/A | 376,100,000.00 | 376,100,000.00 |
| Equity Attributable To Owners Of Parent | N/A | 706,600,000.00 | 709,600,000.00 |
| Noncontrolling Interests | N/A | 0.00 | -4,800,000.00 |
| Liabilities | N/A | 1,398,200,000.00 | 1,532,600,000.00 |
| Noncurrent Liabilities | N/A | 1,144,300,000.00 | 1,230,500,000.00 |
| Deferred Tax Liabilities | N/A | 53,900,000.00 | 57,700,000.00 |
| Noncurrent Derivative Financial Liabilities | N/A | 1,500,000.00 | 0.00 |
| Longterm Borrowings | N/A | 418,600,000.00 | 421,800,000.00 |
| Current Liabilities | N/A | 253,900,000.00 | 302,100,000.00 |
| Current Provisions | N/A | 33,000,000.00 | 44,800,000.00 |
| Trade And Other Current Payables | N/A | 136,900,000.00 | 159,100,000.00 |
| Current Tax Liabilities Current | N/A | 100,000.00 | 3,100,000.00 |
| Current Derivative Financial Liabilities | N/A | 2,500,000.00 | 700,000.00 |
| Line item in (gbp) | 01.01.2020/ 01.01.2021 |
01.01.2021/ 01.01.2022 |
|---|---|---|
| Revenue | 919,900,000.00 | 1,106,200,000.00 |
| Other Income | 400,000.00 | 24,400,000.00 |
| Profit Loss From Operating Activities | -146,200,000.00 | 87,000,000.00 |
| Finance Income | 900,000.00 | 0.00 |
| Finance Costs | 85,700,000.00 | 88,900,000.00 |
| Profit Loss Before Tax | -231,000,000.00 | -1,900,000.00 |
| Income Tax Expense Continuing Operations | 2,900,000.00 | 7,000,000.00 |
| Profit (loss) | -233,900,000.00 | -8,900,000.00 |
| Profit Loss Attributable To Owners Of Parent | -233,900,000.00 | -9,700,000.00 |
| Profit Loss Attributable To Noncontrolling Interests | 0.00 | 800,000.00 |
| Line item in (gbp) | 01.01.2020 | 01.01.2021 | 01.01.2022 |
|---|---|---|---|
| Profit (loss) | N/A | -233,900,000.00 | -8,900,000.00 |
| Adjustments For Reconcile Profit Loss | N/A | 300,000.00 | 0.00 |
| Adjustments For Finance Costs | N/A | 85,700,000.00 | 88,100,000.00 |
| Adjustments For Decrease Increase In Inventories | N/A | -5,600,000.00 | -1,900,000.00 |
| Adjustments For Provisions | N/A | -1,300,000.00 | -2,700,000.00 |
| Adjustments For Sharebased Payments | N/A | 1,700,000.00 | 2,800,000.00 |
| Adjustments For Losses Gains On Disposal Of Noncurrent Assets | N/A | 0.00 | -23,500,000.00 |
| Other Adjustments To Reconcile Profit Loss | N/A | 9,400,000.00 | 11,100,000.00 |
| Adjustments For Reconcile Profit Loss | N/A | 300,000.00 | 0.00 |
| Cash Flows From Used In Operations | N/A | 156,100,000.00 | 183,800,000.00 |
| Income Taxes Paid Refund Classified As Operating Activities | N/A | 3,600,000.00 | 0.00 |
| Cash Flows From Used In Operating Activities | N/A | 159,700,000.00 | 183,800,000.00 |
| Cash Flows Used In Obtaining Control Of Subsidiaries Or Other Businesses Classified As Investing Activities | N/A | 0.00 | 14,700,000.00 |
| Proceeds From Sales Of Property Plant And Equipment Classified As Investing Activities | N/A | 0.00 | 100,000.00 |
| Purchase Of Property Plant And Equipment Classified As Investing Activities | N/A | 46,600,000.00 | 69,300,000.00 |
| Interest Received Classified As Investing Activities | N/A | 100,000.00 | 0.00 |
| Cash Flows From Used In Investing Activities | N/A | -46,300,000.00 | -48,300,000.00 |
| Payments Of Lease Liabilities Classified As Financing Activities | N/A | 13,400,000.00 | 14,700,000.00 |
| Cash Flows From Used In Financing Activities | N/A | -97,900,000.00 | -39,200,000.00 |
| Increase (decrease) in cash and cash equivalents after effect of exchange rate changes | N/A | 15,500,000.00 | 96,300,000.00 |
| Cash and cash equivalents | 90,800,000.00 | 106,300,000.00 | 202,600,000.00 |
Please note that some sums might not add up.
| Position Holder | Short Interest in Percent | Date |
|---|---|---|
| GLG Partners LP | 0.89% | 11.07.23 |
| GLG Partners LP | 0.88% | 14.11.23 |
| GLG Partners LP | 0.90% | 31.08.23 |
| Total | 2.67% |
GB00BNLPYF73
LEI213800IBJPW3SE2RA350
SectorHealth Care Equipment & Services
IndustryHealth Care Providers & Services
Sub-IndustryFTSE 250
Main Stock ExchangeKeep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.